Myriad Genetics Inc. (MYGN)

41.67 -0.32 (-0.762%)

IEX Real-Time Price

August 17, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 41.99

Price Open 41.71

Volume: 514,239

Avg Volume: 771,905

Market Cap: 2.91B

P/E Ratio 36.55

52 Wk Range 27.2275-44.87



MYGN Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
67.29M
9.9M
11.86
14.71%

2018-07-13
67.29M
10.97M
11.00
16.30%

2018-06-29
67.29M
10.61M
13.31
15.77%

2018-06-15
67.29M
11.85M
18.04
17.61%




MYGN Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-08
Q3 2018
BTO
0.27 (9)
0.31
0.04

2018-02-06
Q2 2018
AMC
0.24 (9)
0.31
0.07

2017-11-07
Q1 2018
AMC
0.21 (12)
0.26
0.05

2017-08-08
Q4 2017
AMC
0.26 (8)
0.30
0.04

News

Notable earnings after Tuesday's close (2018-08-13 17:35 SeekingAlpha)

A , CASA , CGC , CREE , FENG , HOLI , MYGN , VIAV , WPM For Seeking Alpha's full earnings season calendar, click here . More news on: Agilent Technologies Inc., Casa Systems, Inc., Canopy Growth Corporation, Earnings news and commentary, ,

 


Statistics

Shares Outstanding: 69.91M

Top 15 Institution Percent: N/A

Price To Sales: 5.08

Price To Book: 3.07

Revenue: 384.20M

Gross Profit: 296.80M

Cash: 291.80M

Debt: N/A

Return On Assets: 11.05

Return On Equity: 16.20

Profit Margin: 21.53

Price History

Beta: 0.39

50-day Moving Avg: 41.05

200-day Moving Avg: 34.99

YTD Change: 19.36

5-day Change: -0.71

1-month Change: -2.69

3-month Change: 19.19

6-month Change: 28.02

1-year Change: 49.57

Revenue Per Share: 5.00

Revenue Per Employee: 160083.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Myriad Genetics Inc.

Exchange: Nasdaq Global Select

Industry: Medical Diagnostics & Research

Sector: Healthcare

Website: http://www.myriad.com

Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.